NCIC Clinical Trials Group

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

Lurtotecan Liposome in Treating Patients With Advanced Solid Tumors

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-06-17

Last Posted Date: 2020-04-09

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 37

Registration Number: NCT00003891

Locations: 🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦
Cancer Care Ontario-Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada

Letrozole in Treating Women With Recurrent or Metastatic Endometrial Cancer

Phase 2

Completed

Conditions: Endometrial Cancer

Interventions: Drug: letrozole

First Posted Date: 2004-06-17

Last Posted Date: 2020-04-06

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 33

Registration Number: NCT00004251

Tamoxifen With or Without Octreotide in Treating Postmenopausal Women With Stage I, Stage II, or Stage III Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: octreotide acetate
Drug: tamoxifen citrate

First Posted Date: 2004-06-16

Last Posted Date: 2020-04-01

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 667

Registration Number: NCT00002864

Locations: 🇺🇸
Duluth Clinic, Duluth, Minnesota, United States
🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦
Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada

and more 37 locations

Topotecan in Treating Patients With Recurrent Brain Tumors

Phase 2

Completed

Conditions: Brain and Central Nervous System Tumors

First Posted Date: 2004-06-09

Last Posted Date: 2020-04-08

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 17

Registration Number: NCT00003372

Locations: 🇨🇦
Kingston Regional Cancer Centre, Kingston, Ontario, Canada
🇨🇦
Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada
🇨🇦
CancerCare Manitoba, Winnipeg, Manitoba, Canada

and more 8 locations

Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer

Phase 3

Completed

Conditions: Pulmonary Complications
Nausea and Vomiting
Quality of Life
Fatigue
Lung Cancer
Pain

First Posted Date: 2004-05-20

Last Posted Date: 2020-04-03

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 230

Registration Number: NCT00003685

Locations: 🇨🇦
Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada
🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
🇨🇦
British Columbia Cancer Agency - Vancouver Island Cancer Centre, Victoria, British Columbia, Canada

and more 18 locations

Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

Interventions: Drug: exemestane

First Posted Date: 2004-05-17

Last Posted Date: 2023-08-25

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 4560

Registration Number: NCT00083174

Locations: 🇺🇸
Trinity Medical Center, Moline, Illinois, United States
🇺🇸
University of California, San Diego, La Jolla, California, United States
🇺🇸
Providence Alaska Medical Center, Anchorage, Alaska, United States

and more 73 locations

Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma

Phase 2

Completed

Conditions: Sarcoma

First Posted Date: 2004-05-03

Last Posted Date: 2020-04-08

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 18

Registration Number: NCT00005974

Locations: 🇨🇦
Nanaimo Cancer Clinic, Nanaimo, British Columbia, Canada
🇨🇦
British Columbia Cancer Agency - Fraser Valley Cancer Centre, Surrey, British Columbia, Canada
🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada

and more 58 locations

Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer

Phase 1

Completed

Conditions: Breast Cancer
Neutropenia

First Posted Date: 2004-04-27

Last Posted Date: 2020-04-01

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 50

Registration Number: NCT00002866

Locations: 🇨🇦
Hotel Dieu de Montreal, Montreal, Quebec, Canada
🇨🇦
Toronto Sunnybrook Regional Cancer Centre, Toronto, Ontario, Canada
🇨🇦
Saint John Regional Hospital, Saint John, New Brunswick, Canada

and more 3 locations

Vinorelbine + Cisplatin or No Further Therapy in Non-small Cell Lung Cancer That Has Been Surgically Removed

Phase 3

Completed

Conditions: Lung Cancer

Interventions: Drug: cisplatin
Drug: vinorelbine ditartrate

First Posted Date: 2004-04-22

Last Posted Date: 2020-04-03

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 482

Registration Number: NCT00002583

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇨🇦
BC Cancer Agency, Vancouver, British Columbia, Canada
🇺🇸
Veterans Affairs Outpatient Clinic - Martinez, Martinez, California, United States

and more 152 locations

High Dose Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Standard Therapy in Treating Women With Metastatic or Recurrent Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer

First Posted Date: 2004-04-14

Last Posted Date: 2020-04-01

Lead Sponsor: NCIC Clinical Trials Group

Target Recruit Count: 224

Registration Number: NCT00003032

Locations: 🇨🇦
Humber River Regional Hospital, Weston, Ontario, Canada
🇨🇦
Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Quebec City, Quebec, Canada
🇨🇦
William Osler Health Centre, Brampton, Ontario, Canada

and more 22 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy